Science Industry Partnership

26 May 2020

Deal for 30 million coronavirus vaccine doses struck between Oxford University and AstraZeneca

SIP member, AstraZeneca has a struck a deal with Oxford University to produce a coronavirus vaccine at scale - pending successful trials. This was announced on the  18th May. 

Business Secretary Alok Sharma said:

"Our scientists are at the forefront of vaccine development. This deal with AstraZeneca means that if the Oxford University vaccine works, people in the UK will get the first access to it, helping to protect thousands of lives.

The agreement will deliver 100 million doses in total, ensuring that in addition to supporting our own people, we are able to make the vaccines available to developing countries at the lowest possible cost.

The UK continues to lead the global response to find a vaccine, and the government is backing our scientists to do this as quickly as possible."